|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
$ r7 i- s" h* @2 Mwas to close its brain research facility in Basel, Switzerland,6 v5 m7 x0 ?. W6 H
the story noted that this move closely followed similar cuts9 y1 x) v6 L* A# \/ y7 }5 v
by rival pharmaceutical firms. As a report from the European College
. K8 F3 i$ e6 P3 r/ R' vof Neuropsychopharmacology" W/ J6 X7 J3 k: I$ Z
had warned a few months earlier, the/ O( C- i! e. ^$ I) F" |! [7 U8 |
abandonment of research into new psychiatric drugs by AstraZeneca,* k# \, `9 \8 }* n `3 Z3 S3 h2 l6 c
GlaxoSmithKline
- L$ R% `4 j6 n( b' Y9 }and others meant that “withdrawal of research. R, x8 r2 _- g1 w
resources is a withdrawal of hope for patients and their families”.3 X1 G4 p7 [5 a: l
y/ d7 B+ n5 h# B1 R/ g( Q, Z9 R; W' `, V; ]1 ^
回复有免费下载链接. V6 _7 G g0 n6 I+ s4 Z
& d* u( W: c1 j
|
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
